APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Therapeutic Vaccines Industry Growth and Trends Forecast to 2032

22 December 202598 pages

Choose your research edition.

Industry ResearchTherapeutic Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Vaccines Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Therapeutic Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Vaccines Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Therapeutic Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Vaccines include Agenus, AVAX Technologies, CIMAB S.A, Corixa, Dendreon, Northeast Biotherapeutics and Vaccinogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Therapeutic Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Vaccines Market by Company

Agenus

AVAX Technologies

CIMAB S.A

Corixa

Dendreon

Northeast Biotherapeutics

Vaccinogen Inc

Therapeutic Vaccines Segment by Type

Nucleic Acid Therapeutic Vaccine

Peptide Therapeutic Vaccine

Cell Therapeutic Vaccine

Therapeutic Vaccines Segment by Application

Oncotherapy

Hepatitis B

Tuberculosis

Herpes Simplex Virus

Others

Therapeutic Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Therapeutic Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nucleic Acid Therapeutic Vaccine Table 2. Major Company of Peptide Therapeutic Vaccine Table 3. Major Company of Cell Therapeutic Vaccine Table 4. Global Therapeutic Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Therapeutic Vaccines Sales by Type (2021-2026) & (k units) Table 6. Global Therapeutic Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Therapeutic Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Therapeutic Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Therapeutic Vaccines Price by Type (2021-2026) & (US$/unit) Table 10. Global Therapeutic Vaccines Sales by Type (2027-2032) & (k units) Table 11. Global Therapeutic Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Therapeutic Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Therapeutic Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Therapeutic Vaccines Price by Type (2027-2032) & (US$/unit) Table 15. North America Therapeutic Vaccines Sales by Type (2021-2026) & (k units) Table 16. North America Therapeutic Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Therapeutic Vaccines Sales by Type (2021-2026) & (k units) Table 18. Europe Therapeutic Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Therapeutic Vaccines Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Therapeutic Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Therapeutic Vaccines Sales by Type (2021-2026) & (k units) Table 22. Latin America Therapeutic Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Therapeutic Vaccines Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Therapeutic Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Therapeutic Vaccines Industry Trends Table 26. Therapeutic Vaccines Industry Drivers Table 27. Therapeutic Vaccines Industry Opportunities and Challenges Table 28. Therapeutic Vaccines Industry Restraints Table 29. Global Therapeutic Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Therapeutic Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Therapeutic Vaccines Sales by Company (2021-2026) & (k units) Table 32. Global Therapeutic Vaccines Sales Share by Company (2021-2026) Table 33. Global Therapeutic Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Therapeutic Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Therapeutic Vaccines Major Company Production Sites and Headquarters Table 36. Global Therapeutic Vaccines Company, Product Type & Application Table 37. Global Therapeutic Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Therapeutic Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Therapeutic Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Therapeutic Vaccines Sales by Region (2021-2026) & (k units) Table 42. Global Therapeutic Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Therapeutic Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Therapeutic Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Therapeutic Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Therapeutic Vaccines Sales by Region (2027-2032) & (k units) Table 47. Global Therapeutic Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Therapeutic Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Therapeutic Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Therapeutic Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Therapeutic Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Therapeutic Vaccines Sales by Application (2021-2026) & (k units) Table 53. Global Therapeutic Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Therapeutic Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Therapeutic Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Therapeutic Vaccines Price by Application (2021-2026) & (US$/unit) Table 57. Global Therapeutic Vaccines Sales by Application (2027-2032) & (k units) Table 58. Global Therapeutic Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Therapeutic Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Therapeutic Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Therapeutic Vaccines Price by Application (2027-2032) & (US$/unit) Table 62. North America Therapeutic Vaccines Sales by Application (2021-2026) & (k units) Table 63. North America Therapeutic Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Therapeutic Vaccines Sales by Application (2021-2026) & (k units) Table 65. Europe Therapeutic Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Therapeutic Vaccines Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Therapeutic Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Therapeutic Vaccines Sales by Application (2021-2026) & (k units) Table 69. Latin America Therapeutic Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Therapeutic Vaccines Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Therapeutic Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Agenus Company Information Table 73. Agenus Business Overview Table 74. Agenus Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Agenus Therapeutic Vaccines Product Portfolio Table 76. Agenus Recent Development Table 77. AVAX Technologies Company Information Table 78. AVAX Technologies Business Overview Table 79. AVAX Technologies Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. AVAX Technologies Therapeutic Vaccines Product Portfolio Table 81. AVAX Technologies Recent Development Table 82. CIMAB S.A Company Information Table 83. CIMAB S.A Business Overview Table 84. CIMAB S.A Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. CIMAB S.A Therapeutic Vaccines Product Portfolio Table 86. CIMAB S.A Recent Development Table 87. Corixa Company Information Table 88. Corixa Business Overview Table 89. Corixa Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Corixa Therapeutic Vaccines Product Portfolio Table 91. Corixa Recent Development Table 92. Dendreon Company Information Table 93. Dendreon Business Overview Table 94. Dendreon Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Dendreon Therapeutic Vaccines Product Portfolio Table 96. Dendreon Recent Development Table 97. Northeast Biotherapeutics Company Information Table 98. Northeast Biotherapeutics Business Overview Table 99. Northeast Biotherapeutics Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio Table 101. Northeast Biotherapeutics Recent Development Table 102. Vaccinogen Inc Company Information Table 103. Vaccinogen Inc Business Overview Table 104. Vaccinogen Inc Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Vaccinogen Inc Therapeutic Vaccines Product Portfolio Table 106. Vaccinogen Inc Recent Development Table 107. North America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. North America Therapeutic Vaccines Sales by Country (2021-2026) & (k units) Table 109. North America Therapeutic Vaccines Sales Market Share by Country (2021-2026) Table 110. North America Therapeutic Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 111. North America Therapeutic Vaccines Sales Market Share Forecast by Country (2027-2032) Table 112. North America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Therapeutic Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Therapeutic Vaccines Market Share by Country (2021-2026) Table 115. North America Therapeutic Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Therapeutic Vaccines Market Share Forecast by Country (2027-2032) Table 117. Europe Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Europe Therapeutic Vaccines Sales by Country (2021-2026) & (k units) Table 119. Europe Therapeutic Vaccines Sales Market Share by Country (2021-2026) Table 120. Europe Therapeutic Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 121. Europe Therapeutic Vaccines Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Therapeutic Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Therapeutic Vaccines Market Share by Country (2021-2026) Table 125. Europe Therapeutic Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Therapeutic Vaccines Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Therapeutic Vaccines Sales by Country (2021-2026) & (k units) Table 129. Asia-Pacific Therapeutic Vaccines Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Therapeutic Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 131. Asia-Pacific Therapeutic Vaccines Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Therapeutic Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Therapeutic Vaccines Market Share by Country (2021-2026) Table 135. Asia-Pacific Therapeutic Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Therapeutic Vaccines Market Share Forecast by Country (2027-2032) Table 137. Latin America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Latin America Therapeutic Vaccines Sales by Country (2021-2026) & (k units) Table 139. Latin America Therapeutic Vaccines Sales Market Share by Country (2021-2026) Table 140. Latin America Therapeutic Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 141. Latin America Therapeutic Vaccines Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Therapeutic Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Therapeutic Vaccines Market Share by Country (2021-2026) Table 145. Latin America Therapeutic Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Therapeutic Vaccines Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Therapeutic Vaccines Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Therapeutic Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 151. Middle East and Africa Therapeutic Vaccines Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Therapeutic Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Therapeutic Vaccines Market Share by Country (2021-2026) Table 155. Middle East and Africa Therapeutic Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Therapeutic Vaccines Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Therapeutic Vaccines Distributors List Table 160. Therapeutic Vaccines Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Therapeutic Vaccines Image Figure 2. Global Therapeutic Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Vaccines Sales (2021-2032) & (k units) Figure 5. Nucleic Acid Therapeutic Vaccine Image Figure 6. Global Nucleic Acid Therapeutic Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Peptide Therapeutic Vaccine Image Figure 8. Global Peptide Therapeutic Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Cell Therapeutic Vaccine Image Figure 10. Global Cell Therapeutic Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Therapeutic Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Therapeutic Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Therapeutic Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Therapeutic Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Therapeutic Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Therapeutic Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Therapeutic Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Therapeutic Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Therapeutic Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Therapeutic Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Therapeutic Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Therapeutic Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Therapeutic Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Oncotherapy Image Figure 26. Global Oncotherapy Sales YoY Growth (2021-2032) & (k units) Figure 27. Hepatitis B Image Figure 28. Global Hepatitis B Sales YoY Growth (2021-2032) & (k units) Figure 29. Tuberculosis Image Figure 30. Global Tuberculosis Sales YoY Growth (2021-2032) & (k units) Figure 31. Herpes Simplex Virus Image Figure 32. Global Herpes Simplex Virus Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Therapeutic Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Therapeutic Vaccines Market Share by Application 2025 VS 2032 Figure 37. North America Therapeutic Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. North America Therapeutic Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Europe Therapeutic Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Europe Therapeutic Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Therapeutic Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Therapeutic Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Latin America Therapeutic Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Therapeutic Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Therapeutic Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Therapeutic Vaccines Sales Market Share in Value by Application in 2025 Figure 47. North America Therapeutic Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Therapeutic Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Therapeutic Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Therapeutic Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Therapeutic Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Therapeutic Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Therapeutic Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Therapeutic Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Therapeutic Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Therapeutic Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Therapeutic Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Therapeutic Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Therapeutic Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Therapeutic Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Therapeutic Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Therapeutic Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Therapeutic Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Therapeutic Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Therapeutic Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Therapeutic Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Therapeutic Vaccines Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Therapeutic Vaccines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acid Therapeutic Vaccine
  • Peptide Therapeutic Vaccine
  • Cell Therapeutic Vaccine
Applications
  • Oncotherapy
  • Hepatitis B
  • Tuberculosis
  • Herpes Simplex Virus
  • Others
Companies covered
  • Agenus
  • AVAX Technologies
  • CIMAB S.A
  • Corixa
  • Dendreon
  • Northeast Biotherapeutics
  • Vaccinogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Therapeutic Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Therapeutic Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Therapeutic Vaccines Market by Type
  6. 1.3.1 Nucleic Acid Therapeutic Vaccine
  7. 1.3.2 Peptide Therapeutic Vaccine
  8. 1.3.3 Cell Therapeutic Vaccine
  9. 1.4 Global Therapeutic Vaccines Market Size by Type
  10. 1.4.1 Global Therapeutic Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Therapeutic Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Therapeutic Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Therapeutic Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Therapeutic Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Therapeutic Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Therapeutic Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Therapeutic Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Therapeutic Vaccines Industry Trends
  2. 2.2 Therapeutic Vaccines Industry Drivers
  3. 2.3 Therapeutic Vaccines Industry Opportunities and Challenges
  4. 2.4 Therapeutic Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Therapeutic Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Therapeutic Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Therapeutic Vaccines Price (2021-2026)
  4. 3.4 Global Therapeutic Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Therapeutic Vaccines Company, Product Type & Application
  7. 3.7 Global Therapeutic Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Vaccines Tier 1, Tier 2, and Tier 3
4 Therapeutic Vaccines Regional Status and Outlook
  1. 4.1 Global Therapeutic Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Therapeutic Vaccines Historic Market Size by Region
  3. 4.2.1 Global Therapeutic Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Therapeutic Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Therapeutic Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Therapeutic Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Therapeutic Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Therapeutic Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Therapeutic Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Therapeutic Vaccines by Application
  1. 5.1 Therapeutic Vaccines Market by Application
  2. 5.1.1 Oncotherapy
  3. 5.1.2 Hepatitis B
  4. 5.1.3 Tuberculosis
  5. 5.1.4 Herpes Simplex Virus
  6. 5.1.5 Others
  7. 5.2 Global Therapeutic Vaccines Market Size by Application
  8. 5.2.1 Global Therapeutic Vaccines Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Therapeutic Vaccines Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Therapeutic Vaccines Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Therapeutic Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Therapeutic Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Therapeutic Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Therapeutic Vaccines Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Therapeutic Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Agenus
  2. 6.1.1 Agenus Company Information
  3. 6.1.2 Agenus Business Overview
  4. 6.1.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Agenus Therapeutic Vaccines Product Portfolio
  6. 6.1.5 Agenus Recent Developments
  7. 6.2 AVAX Technologies
  8. 6.2.1 AVAX Technologies Company Information
  9. 6.2.2 AVAX Technologies Business Overview
  10. 6.2.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AVAX Technologies Therapeutic Vaccines Product Portfolio
  12. 6.2.5 AVAX Technologies Recent Developments
  13. 6.3 CIMAB S.A
  14. 6.3.1 CIMAB S.A Company Information
  15. 6.3.2 CIMAB S.A Business Overview
  16. 6.3.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CIMAB S.A Therapeutic Vaccines Product Portfolio
  18. 6.3.5 CIMAB S.A Recent Developments
  19. 6.4 Corixa
  20. 6.4.1 Corixa Company Information
  21. 6.4.2 Corixa Business Overview
  22. 6.4.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Corixa Therapeutic Vaccines Product Portfolio
  24. 6.4.5 Corixa Recent Developments
  25. 6.5 Dendreon
  26. 6.5.1 Dendreon Company Information
  27. 6.5.2 Dendreon Business Overview
  28. 6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dendreon Therapeutic Vaccines Product Portfolio
  30. 6.5.5 Dendreon Recent Developments
  31. 6.6 Northeast Biotherapeutics
  32. 6.6.1 Northeast Biotherapeutics Company Information
  33. 6.6.2 Northeast Biotherapeutics Business Overview
  34. 6.6.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
  36. 6.6.5 Northeast Biotherapeutics Recent Developments
  37. 6.7 Vaccinogen Inc
  38. 6.7.1 Vaccinogen Inc Company Information
  39. 6.7.2 Vaccinogen Inc Business Overview
  40. 6.7.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio
  42. 6.7.5 Vaccinogen Inc Recent Developments
7 North America by Country
  1. 7.1 North America Therapeutic Vaccines Sales by Country
  2. 7.1.1 North America Therapeutic Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Therapeutic Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Therapeutic Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Therapeutic Vaccines Market Size by Country
  6. 7.2.1 North America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Therapeutic Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Therapeutic Vaccines Sales by Country
  2. 8.1.1 Europe Therapeutic Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Therapeutic Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Therapeutic Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Therapeutic Vaccines Market Size by Country
  6. 8.2.1 Europe Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Therapeutic Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Therapeutic Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Therapeutic Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Therapeutic Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Therapeutic Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Therapeutic Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Therapeutic Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Therapeutic Vaccines Sales by Country
  2. 10.1.1 South America Therapeutic Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Therapeutic Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Therapeutic Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Therapeutic Vaccines Market Size by Country
  6. 10.2.1 South America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Therapeutic Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Therapeutic Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Therapeutic Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Therapeutic Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Therapeutic Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Therapeutic Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Therapeutic Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Therapeutic Vaccines Value Chain Analysis
  2. 12.1.1 Therapeutic Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Therapeutic Vaccines Production Mode & Process
  7. 12.2 Therapeutic Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Therapeutic Vaccines Distributors
  10. 12.2.3 Therapeutic Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst